With the start of this clinical trial, we aim to provide solutions for patients who either need to stop or wish to stop injectable weight loss medications like GLP-1 therapy. Patients participating in the REMAIN-1 study will undergo the procedure at St
In one sense, this is accurate
Proteins were detected via western blotting with the following antibodies: pSTAT3 1:1000 (D3A7), STAT3 1:1000 (79D7), SHP2 1:1000 (D50F2), pAKTS473 1:1000 (D9E), AKT 1:1000 (C67E7), pERKT202/Y204 1:1000 (D13.14
If you have underlying medical conditions or allergies, tell your healthcare provider before undergoing the treatment
Gut health and GI inflammation Oral or sublingual BPC-157 is the preferred route for GI indications
Reproducibility, temporal variability, and concordance of serum and fecal bile acids and short chain fatty acids in a population-based study